Advanced search
Publication Cover
Expert Opinion on Drug Discovery Volume 10, 2015 - Issue 7
Submit an article Journal homepage
689
Views
7
CrossRef citations to date
0
Altmetric
Drug Discovery Case History

The preclinical discovery of rituximab for the treatment of non-Hodgkin’s lymphoma

Piotr SmolewskiMedical University of Lodz, Department of Experimental Hematology, Ciolkowskiego 2, Lodz, 93-510 Poland
&
Tadeusz RobakMedical University of Lodz, Copernicus Memorial Hospital, Department of Hematology, Ciolkowskiego 2, 93-510 Lodz, [email protected]
(Professor)
Pages 791-808 | Published online: 17 Jun 2015

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

J. M. L. Casan, J. Wong, M. J. Northcott & S. Opat. (2018) Anti-CD20 monoclonal antibodies: reviewing a revolution. Human Vaccines & Immunotherapeutics 14:12, pages 2820-2841.
Read now

Articles from other publishers (6)

Joana N. R. Dias, André Almeida, Ana S. André, Sandra I. Aguiar, Pedro Bule, Sara Nogueira, Soraia S. Oliveira, Belmira Carrapiço, Solange Gil, Luís Tavares & Frederico Aires-da-Silva. (2022) Characterization of the canine CD20 as a therapeutic target for comparative passive immunotherapy. Scientific Reports 12:1.
Crossref
Helen J. McBride, Shea Jassem, Vincent Chow, Palanisamy Kanakaraj, Herve Lebrec, Scott Kuhns, John Ferbas, Min Wong & Theingi M. Thway. (2021) Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. Biologicals 72, pages 42-53.
Crossref
Andrea MarcinnòFabiana MarnettoPaola ValentinoSerena MartireAlessia BalboAurora DragoMaria LetoMarco CapobiancoGiancarlo PanzicaAntonio Bertolotto. (2018) Rituximab-induced hypogammaglobulinemia in patients with neuromyelitis optica spectrum disorders. Neurology Neuroimmunology & Neuroinflammation 5:6.
Crossref
Luis Mario Villela-Ma, Ana Karen Velez-Ayal, Rosa del Carmen Lopez-Sanc, Jorge A Martinez-C & Jose A Hernandez-. (2017) Advantages of Drug Selective Distribution in Cancer Treatment: Brentuximab Vedotin. International Journal of Pharmacology 13:7, pages 785-807.
Crossref
Mark T. Winkler, Ryan T. Bushey, Elizabeth B. Gottlin, Michael J. Campa, Eross S. Guadalupe, Alicia D. Volkheimer, J. Brice Weinberg & Edward F. Patz. (2017) Enhanced CDC of B cell chronic lymphocytic leukemia cells mediated by rituximab combined with a novel anti-complement factor H antibody. PLOS ONE 12:6, pages e0179841.
Crossref
Javeed Iqbal, Hina Naushad, Chengfeng Bi, Jiayu Yu, Alyssa Bouska, Joseph Rohr, Wang Chao, Kai Fu, Wing C. Chan & Julie M. Vose. (2016) Genomic signatures in B-cell lymphoma: How can these improve precision in diagnosis and inform prognosis?. Blood Reviews 30:2, pages 73-88.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.